WBA Stock Recent News
WBA LATEST HEADLINES
Can this pharmacy retailer overcome this latest threat?
Walgreens (NASDAQ: WBA) is scheduled to report its fiscal Q4 2024 results on Tuesday, October 15 (Walgreens' fiscal ends in August). We expect the company to post mixed results, with revenue of $34.9 billion and earnings of $0.38 per share, compared to the consensus estimates of $35.7 billion and $0.36, respectively.
Long-established in the Healthcare Providers & Services industry, Walgreens Boots Alliance Inc (WBA, Financial) has enjoyed a stellar reputation. It has recently witnessed a daily gain of 0.17%, juxtaposed with a three-month change of -13.27%.
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $8.88, denoting a +1.83% change from the preceding trading day.
A challenging retail environment and pharmacy trends are expected to cloud Walgreens' performance in the fourth quarter of fiscal 2024.
In addition to weak consumer behavior and retail pharmacy industry headwinds, app downloads data suggests Walgreens is lagging vs. competition such as CVS. WBA has missed on margin expectations for multiple quarters now, and these pressures are expected to continue due to a tough pricing environment. Despite trough discount valuations vs. comps, WBA stock is in a value trap as the stock falls primarily due to earnings downgrades in the absence of catalysts.
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens, the leading independent retail pharmacy and healthcare provider, is announcing today the launch of the Walgreens Student Loan 401(k) Match Program. This new benefit, available beginning in January 2025, will allow team members to qualify for company 401(k) match contributions as they pay down their student loans. “We understand the burden student loan debt places on many of our team members, and this program empowers us to make a lasting impact on th.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) common stock between July 1, 2021 and June 26, 2024, inclusive (the “Class Period”). Walgreens investors have until November 18, 2024 to file a lead plaintiff motion. If you suffered a loss on.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Walgreens Boots Alliance, Inc. (WBA) Investors.